FDA Inspection 961417 — Nebraska Methodist Hospital IRB
The FDA completed an inspection of Nebraska Methodist Hospital IRB on Feb 17, 2016 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 17, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Omaha, NE (United States)
Additional Details
IRB